Intracranial Hemorrhage Detection Software Receives FDA Clearance

“AI and machine learning are going to transform healthcare, as they have virtually every other industry they have touched,” said Gene Saragnese, chairman and CEO of MaxQ AI in an interview with MD+DI. “Our world is surrounded by algorithms that present information, but one place it’s been lacking is healthcare.” MaxQ AI is doing its best to remedy that deficiency, starting with software that can detect intracranial hemorrhage (ICH). The company’s recently FDA-cleared Accipio Ix is used with noncontrast computed tomography (CT). It can be natively integrated into CT machines and Picture Archiving and Communication Systems (PACS), using the imaging industry standard DICOM, installed both on premise and cloud capable. When a patient comes into the emergency room with a head injury or symptoms of a stroke, one of the first things a physician wants to find out is if there is blood present in the brain, said Saragnese. But ICH can be hard to see on CT, as they can be very small and subtle. “So our software takes a noncontrast CT and processes it in the background using an algorithm,” he explained. “It identifies a patient who has potential intracranial hemorrhaging, and it highlights that patient is to be prioritized, so that person could be moved higher in the list to be examined.”...
Source: MDDI - Category: Medical Devices Authors: Tags: Digital Health Source Type: news